Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Featured Article
François Torche dispels the myth that, at least in RBQM, there is such a thing as...
Source: PM360
- Featured Article
An increase in clinical trial data is driving demand for enhanced clinical trial processes. Sponsors want...
Source: Journal for Clinical Studies
- Featured Article
With increasing pressure to overcome drug development challenges and advance drugs to market faster and with...
Source: Contract Pharma
- Featured Article
Today’s drug development landscape demands contract research organizations (CROs) provide flexible models that leverage the latest...
Source: Contract Pharma
- Featured Article
In an interview with ACT editor Andy Studna at DIA 2024, Hughes, co-founder and chief commercial...
Source: Applied Clinical Trials
- Press Release
Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...
- Featured Article
Over the past 10 years we have seen a lot of progress in risk-based quality management...
Source: ACRP
- Press Release
CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in...
- Press Release
KING OF PRUSSIA, Pa., — CluePoints, provider of leading statistical and AI-driven software solutions, today unveiled...
- Featured Article
We presented an initial review of quality tolerance limit (QTL) adoption trends in the March 2023...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Press Release
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of...
- Press Release
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT...
- Press Release
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational...
- Press Release
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
- Press Release
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is now open....
- Press Release
Are you struggling with how to assess the true value of improving data quality and integrity...
- Press Release
The other week, CluePoints in conjunction with HighPoint Solutions delivered 3 European Roadshows in Basel, Copenhagen...
- Press Release
Wayne, PA – October 02, 2018: CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data...
- Press Release
Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints to...
- Press Release
Since the initial publication of the ICH GCP guidelines, the way clinical trials operate has changed...
- Featured Article
CluePoints Co-Founder and Chief Product & Technology Officer François Torche discusses the challenges of collecting clinical...
Source: DIA
- Featured Article
Artificial intelligence (AI) has massive potential to advance clinical research.
...Source: DIA
- Featured Article
At the recent DIA 2023 Global Annual Conference, I focused my attention on discussions about the...
Source: Clinical Research News
- Featured Article
CluePoints Co-Founder and Chief Product & Technology Officer François Torche discusses the challenges of collecting clinical...
Source: DIA
- Featured Article
A conversation with Steve Young, member of Avoca Quality Consortium, PHUSE Working Group participant, and Tufts...
Source: Clinical Leader
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
